Paola Parrella

10PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Cancer diagnosisPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 27, 2026
Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy.

|Dec 08, 2025
Comprehensive Molecular Screening by Next Generation Sequencing of Gastrointestinal Stromal Tumors (GISTs): In Silico Analysis and Classification of Rare KIT Exon 11 Mutations.

Maria Grazia Rodriquenz, Barbara Pasculli, Michelina Rendina

|Sep 13, 2025
KRAS Mutations in Colorectal Adenocarcinoma: Incidence and Association with Histological Features with Particular Reference to Gly12Asp in a Multicenter GIPAD Real-World Study.

Paola Parente, Valentina Angerilli, Federica Grillo

|Nov 27, 2024
Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer.

Paola Parrella, Raffaela Barbano, Katharina Jonas

|Apr 12, 2022
The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy.

Brigida Anna Maiorano, Domenica Lorusso, Mauro Francesco Pio Maiorano

|Jul 24, 2020
Pro-Fibrotic Phenotype in a Patient with Segmental Stiff Skin Syndrome via TGF-β Signaling Overactivation.

Carmela Fusco, Grazia Nardella, Bartolomeo Augello

Pageof 2

Frequent Collaborators

6 joint publications

Barbara Pasculli

4 joint publications

Paolo Graziano

2 joint publications

Andrea Fontana

2 joint publications

Evaristo Maiello